Indegene Ltd

  • BSE Code : 544172
  • NSE Symbol : INDGN
  • ISIN : INE065X01017
  • Industry :MISCELLANEOUS

up-arrow 472.60 8.05(1.73%)

Open Price ()

462.15

Prev. Close ()

464.55

Volume (No’s)

186,598

Market Cap ()

11,380.31

Low Price ()

448.15

High Price ()

475.95

 

Book Closure

From Date To Date Announcement
23-Mar-2026 NA In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from March 23, 2026 along with the designated security codes thereof shall be as specified in the Annexure. In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure. For the purpose of trading on the system, the security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure. This circular shall be effective from March 23, 2026. Symbol INDGN Name of the Company Indegene Limited Series EQ ISIN* INE065X01017 Face Value (In Rs.) 2 Paid-up Value (In Rs.) 2 Security Description Equity shares of Rs. 2/- each allotted under ESOP. Date of Allotment 20-Feb-2026 No. of Securities 5794 Distinctive Number Range 240802171 to 240807964 Market Lot 1 Pari Passu Yes Lock-in details Not Applicable. * Currently equity shares allotted in dematerialized mode have been credited under the temporary ISIN (IN8*********) in accordance with the SEBI circular no. CIR/MRD/DP/21/2012 dated August 02, 2012 and CIR/MRD/DP/24/2012 dated September 11, 2012 regarding activation of ISIN in case of additional issue of shares / securities.
23-Mar-2026 NA In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from March 23, 2026 along with the designated security codes thereof shall be as specified in the Annexure. In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure. For the purpose of trading on the system, the security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure. This circular shall be effective from March 23, 2026. Symbol INDGN Name of the Company Indegene Limited Series EQ ISIN* INE065X01017 Face Value (In Rs.) 2 Paid-up Value (In Rs.) 2 Security Description Equity shares of Rs. 2/- each allotted under ESOP. Date of Allotment 20-Feb-2026 No. of Securities 322086 Distinctive Number Range 240480085 to 240802170 Market Lot 1 Pari Passu Yes Lock-in details Not Applicable. * Currently equity shares allotted in dematerialized mode have been credited under the temporary ISIN (IN8*********) in accordance with the SEBI circular no. CIR/MRD/DP/21/2012 dated August 02, 2012 and CIR/MRD/DP/24/2012 dated September 11, 2012 regarding activation of ISIN in case of additional issue of shares / securities.
04-Mar-2026 NA All market participants are hereby informed that the further new securities issued by the under mentioned Companies are listed and admitted for trading on the Exchange with effect from Wednesday, March 4, 2026. Name of the Company Indegene Limited ISIN INE065X01017 Scrip Code 544172 No Of Shares 13332 Face Value 2 Dist Nos.From 240466753 Dist Nos.To 240480084 Date Upto Which Under lock-in NA
29-Jan-2026 NA Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 inter alia to consider and approve the unaudited consolidated and standalone financial results of the Company for the quarter ended December 31 2025 along with the limited review report of the Auditors thereon. Financial results with Limited review report (As Per BSE Announcement Dated On : 29.01.2026)
25-Jan-2026 NA Appointment

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew